Hepatitis C

Preventive Care Coverage Threatened by Federal Court Ruling

Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs

Administrative Complaint Against the Mississippi Medicaid Agency

Public Comment: HCV Elimination Plan Presentation

Hepatitis C: State of Medicaid Access: 2022 National Summary Report

Administrative Complaint Against the Alabama Medicaid Agency

Hepatitis C: The State of Medicaid Access January 2022 Snapshot

Hepatitis C: The State of Medicaid Access: May 2021 National Progress Report

State Policies Limiting Progress Towards HCV Elimination in the U.S.

Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs

Pin It on Pinterest